Drugs / Magnesium L-threonate
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06959745 | May → Sep 2025 overdue | magnesium deficiency | Guangdong Provincial People's Hospital | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Magnesium L-threonate | “Magnesium L-threonate, 1740 mg, taken orally, twice a day, for 8 weeks.” NCT06959745 ↗ |
| Route | Oral | “Magnesium L-threonate, 1740 mg, taken orally, twice a day, for 8 weeks.” NCT06959745 ↗ |